Drug Profile
Anti-CD3 monoclonal antibody CD4IgG conjugate
Alternative Names: Bispecific immunoadhesin antibodyLatest Information Update: 17 Nov 2006
Price :
$50
*
At a glance
- Originator Genentech
- Class Antivirals; Bispecific antibodies; Drug conjugates; Immunoconjugates; Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 02 Jul 1998 No-Development-Reported for HIV infections treatment in USA (Unknown route)
- 01 Dec 1994 Preclinical development for HIV infections treatment in USA (Unknown route)